It’s no secret that psychedelics are on the comeback trail, with a record number of trials and total investment in the hundreds of millions of dollars in 2021 alone. This interest – from the public, investors, and researchers alike – has made 2021 the biggest year for psychedelics research to date – and 2022 is set to be even bigger…